Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.3 CAD | -4.90% | -7.04% | -16.46% |
Jun. 07 | Transcript : HLS Therapeutics Inc. - Shareholder/Analyst Call | |
May. 28 | HLS Therapeutics Notes Role of Pharmaceutical Support Programs on Persistence with Clozapine Treatment in Quebec Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.46% | 80.25M | |
+29.04% | 76.68B | |
+0.15% | 24.41B | |
+11.60% | 8.48B | |
-25.74% | 7.47B | |
+14.29% | 5.21B | |
-0.34% | 4.12B | |
-10.28% | 3.86B | |
-5.96% | 3.56B | |
+12.86% | 3.4B |
- Stock Market
- Equities
- HLS Stock
- News HLS Therapeutics Inc.
- HLS Therapeutics Reiterated at Buy at Stifel GMP on Rising Sales; Price Target Kept at C$32.00